The 2017/18 publication explores the evolution of tobacco science and highlights our world class alternatives to smoking. It also reinforces our commitment to providing open and transparent communications around our non-competitive science.
A new-to-the-world technology that could revolutionise vaping is showcased in the report, with Austrian inventor Helmut Buchberger discussing the innovative plate-based technology featured in the upcoming Vype iSwitch, which is due to be launched later this year.
Our 2015 Science and Technology Report won the ‘Most Impressive Public Service Initiative’ award at the 2016 Global Tobacco and Nicotine Forum (GTNF) conference in Brussels. Building on that success, our latest report has been designed to reach a broader audience, and the eBook features six videos and various animations.
Our latest clinical studies, in vitro testing, and population studies are all featured in the report, along with articles on Japan’s experience with the flagship THP glo and updates on our other nicotine delivery products.
Chris Proctor, BAT’s Chief Scientific Officer, said: “This is our third science and technology report and illustrates great progress in bringing new technologies from concept to consumers, supported by the most advanced science programme we have ever had, demonstrating the harm reduction potential of these new products.”
Download the report from the Apple iBooks Store and www.bat-science.com/sciencereport. For printed copies, please contact firstname.lastname@example.org.
Notes to Editors
About British American Tobacco: British American Tobacco is a global tobacco and Next Generation Product company with brands sold in more than 200 markets. It employs more than 50,000 people worldwide and has over 200 brands in its portfolio, with its cigarettes chosen by one in eight of the world’s one billion smokers. Leading global brands include Dunhill, Kent, Pall Mall and Lucky Strike.
About Next Generation Products (NGP): Next Generation Products is part of the British American Tobacco Group and is focused on developing and delivering high-quality alternative nicotine and tobacco products for adult consumers in the key areas of Vapour, Oral and Tobacco Heating Products. For more information see www.goVype.com and www.bat-science.com.
About Tobacco Harm Reduction: The only way to avoid the risks associated with tobacco use is not to consume tobacco at all, and the best way to reduce the risks is to stop using tobacco. However, the concept of harm reduction is increasingly being considered in relation to tobacco use. Harm reduction is about finding practical ways to minimise the health impact of an inherently risky activity or behaviour, without seeking to stop it entirely. It is a key element of BAT’s business strategy and is being discussed by some regulators. We think it’s important to work towards producing consumer-acceptable, potentially reduced risk products. We believe that tobacco regulatory policies should include harm reduction approaches for the millions of adults globally who will continue to consume tobacco products.
The Public Health Impact of e-cigarettes: Many in the public health community believe e-cigarettes offer great potential for contributing to tobacco harm reduction policies. A 2018 updated evidence review by Public Health England*, an executive body of the UK Department of Health, concludes that vaping is around 95% less harmful than smoking cigarettes. The UK’s Royal College of Physicians have said that the public can be reassured that e-cigarettes are much safer than smoking and that they should be widely promoted as a substitute for smoking.
For more information: email Joanna_Hunt@bat.com or call +44 (0)7858 375461